- Home
- THAR vs APDN Comparison
THAR vs APDN Comparison
Compare THAR & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- APDN
- Stock Information
- Founded
- THAR 2017
- APDN 1983
- Country
- THAR United States
- APDN United States
- Employees
- THAR N/A
- APDN N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- THAR Health Care
- APDN Consumer Discretionary
- Exchange
- THAR Nasdaq
- APDN Nasdaq
- Market Cap
- THAR 2.8M
- APDN 3.3M
- IPO Year
- THAR 2022
- APDN N/A
- Fundamental
- Price
- THAR $2.17
- APDN $0.16
- Analyst Decision
- THAR
- APDN Strong Buy
- Analyst Count
- THAR 0
- APDN 1
- Target Price
- THAR N/A
- APDN $1.50
- AVG Volume (30 Days)
- THAR 3.3M
- APDN 4.9M
- Earning Date
- THAR 11-07-2024
- APDN 12-05-2024
- Dividend Yield
- THAR N/A
- APDN N/A
- EPS Growth
- THAR N/A
- APDN N/A
- EPS
- THAR N/A
- APDN N/A
- Revenue
- THAR N/A
- APDN $3,398,049.00
- Revenue This Year
- THAR N/A
- APDN N/A
- Revenue Next Year
- THAR N/A
- APDN $48.01
- P/E Ratio
- THAR N/A
- APDN N/A
- Revenue Growth
- THAR N/A
- APDN N/A
- 52 Week Low
- THAR $1.84
- APDN $0.15
- 52 Week High
- THAR $79.50
- APDN $22.80
- Technical
- Relative Strength Index (RSI)
- THAR 44.85
- APDN 28.68
- Support Level
- THAR $1.90
- APDN $0.17
- Resistance Level
- THAR $2.33
- APDN $0.21
- Average True Range (ATR)
- THAR 0.54
- APDN 0.02
- MACD
- THAR -0.04
- APDN 0.02
- Stochastic Oscillator
- THAR 6.22
- APDN 9.09
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.